Institute of Translational Oncology Research

Greenville, South Carolina 29605

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Non-small Cell Lung Cancer, Pancreatic Cancer, Small Cell Lung Cancer

Studies at this site

• A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies. — Withdrawn before enrolling
• A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors — Completed
• A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer — Completed